These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
682 related articles for article (PubMed ID: 20853577)
1. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells. Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE; Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577 [TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of 1,3-butadiene and its epoxy intermediates. Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF; Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413 [TBL] [Abstract][Full Text] [Related]
3. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites. Walker VE; Meng Q Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840 [TBL] [Abstract][Full Text] [Related]
4. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L; Saranko CJ; Steen AM Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [TBL] [Abstract][Full Text] [Related]
5. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene. Blair IA; Oe T; Kambouris S; Chaudhary AK Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841 [TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of stereochemical configurations of 1,2-epoxybutene and 1,2:3,4-diepoxybutane in human lymphblastoid cells. Meng Q; Redetzke DL; Hackfeld LC; Hodge RP; Walker DM; Walker VE Chem Biol Interact; 2007 Mar; 166(1-3):207-18. PubMed ID: 16854403 [TBL] [Abstract][Full Text] [Related]
7. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism. Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842 [TBL] [Abstract][Full Text] [Related]
8. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol. Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494 [TBL] [Abstract][Full Text] [Related]
9. Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene. Meng Q; Walker DM; McDonald JD; Henderson RF; Carter MM; Cook DL; McCash CL; Torres SM; Bauer MJ; Seilkop SK; Upton PB; Georgieva NI; Boysen G; Swenberg JA; Walker VE Chem Biol Interact; 2007 Mar; 166(1-3):121-31. PubMed ID: 16945358 [TBL] [Abstract][Full Text] [Related]
10. Persistence of N7-(2,3,4-trihydroxybutyl)guanine adducts in the livers of mice and rats exposed to 1,3-butadiene. Oe T; Kambouris SJ; Walker VE; Meng Q; Recio L; Wherli S; Chaudhary AK; Blair IA Chem Res Toxicol; 1999 Mar; 12(3):247-57. PubMed ID: 10077487 [TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats. Meng Q; Henderson RF; Walker DM; Bauer MJ; Reilly AA; Walker VE Mutat Res; 1999 Aug; 429(1):127-40. PubMed ID: 10434028 [TBL] [Abstract][Full Text] [Related]
12. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity. Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618 [TBL] [Abstract][Full Text] [Related]
13. Measurement of plasma or urinary metabolites and Hprt mutant frequencies following inhalation exposure of mice and rats to 3-butene-1,2-diol. Walker DM; McDonald JD; Meng Q; Kracko DA; Bauer MJ; Seilkop SK; Walker EL; Henderson RF; Walker VE Chem Biol Interact; 2007 Mar; 166(1-3):191-206. PubMed ID: 17316587 [TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399 [TBL] [Abstract][Full Text] [Related]
17. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396 [TBL] [Abstract][Full Text] [Related]
18. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine. Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386 [TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of hprt mutant lymphocytes from 1, 3-butadiene-exposed workers. Ma H; Wood TG; Ammenheuser MM; Rosenblatt JI; Ward JB Environ Mol Mutagen; 2000; 36(1):59-71. PubMed ID: 10918361 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger. Meng Q; Su T; O'Neill JP; Walker VE Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]